Exabis Library
Welcome to the e-CCO Library!
P281: Conversion of the ileal pouch-anal anastomosis to a continent ileostomy – outcome and patient satisfaction
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P281: Endoscopic healing assessed by advanced optical enhancement techniques combined with faecal calprotectin (FCP) can accurately assess histological healing in ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P281: Evaluation of trough level and disease activity after switch from adalimumab originator to biosimilar in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P281: Factors at diagnosis associated with disabling disease course in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P281: One simple question is sufficient for measuring medication adherence in inflammatory bowel disease patients using self-report
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P281: TELEIBD: A telematic fast-track pathway for patients with high suspicion of Inflammatory Bowel Disease in primary care.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P282 Early disease acceleration in patients with newly diagnosed Crohn’s disease in India and Israel: Insights from an East-West inception cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P282: Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P282: Despite surveillance and increased use of biologics and immunosuppressives colorectal cancer detection in IBD patients remains unchanged over the past ten years
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P282: Does colonoscopy alter the post-procedural fecal calprotectin results in Crohn's disease patients with ileocecal resection?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P282: High plasma oncostatin-M predicts non-response to tumour necrosis factor-alpha antagonists in inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P282: Influence of phenotype at diagnosis and of other potential prognostic factors on the prognosis of Crohn’s Disease in Chinese population
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P282: Isolated colonic Crohn's disease and extensive ulcerative colitis: is there a reel difference?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P282: The long-term effect of biologics in newborns
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P283 Patient-reported symptoms over a period of 14 days reliably predict endoscopic and histological disease activity in ulcerative colitis (UC)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P283: Awareness and perceptions of colorectal cancer risk and screening in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P283: Bowel urgency in patients with moderate to severe ulcerative colitis: prevalence and correlation with clinical outcomes, biomarker levels, and health-related quality of life from U-ACHIEVE, a Phase 2b study of upadacitinib
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P283: Decrease in bowel wall thickness at intestinal ultrasound accurately detects early endoscopic remission and improvement in ulcerative colitis patients on tofacitinib: a longitudinal prospective cohort study.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P283: Development, validation and clinical application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease: IBD-KNOW
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P283: Infliximab re-challenge: could it be an option in refractory IBD patients?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM